Shalby Delivers Healthy Q4 Performance With Steady Profit Growth

Operating Momentum In Core Healthcare Business

For Q4, Shalby’s consolidated revenue from operations stood at Rs 2.87 billion, reflecting continued traction in orthopaedics, joint replacement, multi-speciality surgeries and allied healthcare services. The company’s focus on clinical excellence, patient volumes and operational efficiency supported steady topline growth during the quarter.

Profitability And Margin Trends

Consolidated net profit for the March quarter came in at Rs 183.2 million, indicating disciplined cost control and measured capacity utilisation across hospitals. Despite inflationary pressures on manpower, consumables and diagnostics, Shalby managed to maintain a healthy margin profile, aided by better case mix and higher-value procedures.

What The Results Mean For Outlook

The combination of stable revenues and consistent profitability improves Shalby’s visibility on earnings and cash flows. Investors will be tracking management commentary on bed additions, occupancy levels, new centres, asset-light expansion, and any guidance on capital expenditure and debt in the coming quarters.

Key Highlights

1. March quarter consolidated revenue from operations at Rs 2.87 billion
2. March quarter consolidated net profit reported at Rs 183.2 million
3. Performance supported by steady demand across key specialties and hospitals
4. Margins benefit from improved case mix and operating efficiency
5. Future focus likely on expansion, occupancy improvement and disciplined capex

Sources: Company results announcement, stock exchange filing, Shalby Ltd Q4 FY26 financial disclosure